Results 11 to 20 of about 2,960,910 (293)
Tumor Biology, 2018 Biomarkers are the key to personalized treatment in patients with breast cancer. While tissue biomarkers are most useful in determining prognosis and upfront predicting response to therapy, circulating protein biomarkers such as CA 15-3 and ...
Michael J Duffy +2 more
doaj +3 more sources
The Journal of Molecular Diagnostics, 2023 For patients with BRAF wild-type stage III and IV melanoma, there is an urgent clinical need to identify prognostic biomarkers and biomarkers predictive of treatment response.
Lauren G. Aoude +13 more
openaire +2 more sources
Role of circulating tumor DNA and circulating tumor cells in breast cancer: History and updates [PDF]
SAGE Open Medicine, 2022 Circulating tumor DNA, cell-free DNA, and circulating tumor cells have been at the epitome of recent research in breast cancer. These forms of liquid biopsies have been used in monitoring disease progression, estimating the risk of relapse, and response ...
Julien Chedid +5 more
doaj +2 more sources
Circulating Tumor DNA in Pediatric Cancer
Frontiers in Molecular Biosciences, 2022 The measurement of circulating tumor DNA (ctDNA) has gained increasing prominence as a minimally invasive tool for the detection of cancer-specific markers in plasma.
Louise Doculara +11 more
doaj +4 more sources
Clinical correlates of circulating cell-free DNA tumor fraction.
PLoS ONE, 2021 BackgroundOncology applications of cell-free DNA analysis are often limited by the amount of circulating tumor DNA and the fraction of cell-free DNA derived from tumor cells in a blood sample.
Joerg Bredno +4 more
doaj +2 more sources
Circulating tumor DNA as prognostic markers for late stage NSCLC with bone metastasis
The International Journal of Biological Markers, 2018 Purpose: Bone metastases from non-small cell lung cancer (NSCLC) are common, and current prognostic stratification methods are challenging to predict outcomes.
Jiguang Jia +3 more
doaj +2 more sources
, 2021 Analysis of tutor circulating DNA using Next Generation ...
Alexandru Salceanu (9303227)
openaire +2 more sources
Early detection of recurrent HPV+ hypopharyngeal squamous cell carcinoma by circulating tumor DNA
Otolaryngology Case Reports, 2023 Circulating tumor DNA is a liquid biomarker that offers a highly specific method to assess HPV-associated tumor burden via a blood draw. It has the potential for many clinical applications in cancer care, including prognostication, monitoring treatment ...
Derek D. Kao +2 more
doaj +2 more sources
Analytical evaluation of circulating tumor DNA sequencing assays
Scientific ReportsIn China, circulating tumor DNA analysis is widely used and numerous assays are available. Systematic evaluation to help users make informed selections is needed.
Wenjin Li +6 more
doaj +2 more sources
Fragment Length of Circulating Tumor DNA.
PLoS Genetics, 2016 Malignant tumors shed DNA into the circulation. The transient half-life of circulating tumor DNA (ctDNA) may afford the opportunity to diagnose, monitor recurrence, and evaluate response to therapy solely through a non-invasive blood draw.
Hunter R Underhill +9 more
doaj +3 more sources